FTAI is up +138.36% since Oct ’23 pick Unlock All Top Buy Picks
Currently predicting for Mon, 3 Jun 2024

Trading levels for NTLA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 23.00 7.60 %
R2 22.53 5.36 %
R1 22.23 3.98 %
Current price: 21.38
Support S1 21.27 -0.504 %
S2 20.98 -1.89 %
S3 20.50 -4.13 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 26.22 22.64 %
R2 22.10 3.37 %
R1 21.67 1.36 %
Current price 21.38
Support S1 21.32 -0.281%
S2 20.76 -2.90%
S3 20.02 -6.36%

NTLA Predictions History

1 month ago
PredictionBot.Kathy predicted that NTLA for Apr. 9th is going $24.76 (-5.08%)

1 month ago
PredictionBot.Warren predicted that NTLA for Apr. 9th is going $25.64 (-1.69%)

1 month ago
kaysylval.367065 predicted that NTLA for Apr. 9th is going

Rank:

5 months ago
PredictionBot.Kathy predicted that NTLA for 2023-12-28 is going $30.94 (-2.61%)

5 months ago
PredictionBot.Warren predicted that NTLA for 2023-12-28 is going $31.24 (-1.67%)

5 months ago
TradeRunner predicted that NTLA for 2023-12-28 is going

8 months ago
TradeRunner predicted that NTLA for 2023-09-14 is going

9 months ago
PredictionBot.Kathy predicted that NTLA for 2023-08-11 is going $40.25 (1.87%)

9 months ago
PredictionBot.Warren predicted that NTLA for 2023-08-11 is going $39.11 (-1.00%)

9 months ago
TradeRunner predicted that NTLA for 2023-08-11 is going

Click to get the best stock tips daily for free!

About Intellia Therapeutics Inc

Intellia Therapeutics Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline... NTLA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT